Seer, Inc. (SEER) stock
Close on Nov 12, 2026Market cap $88.04MP/E –Yield 0.00%
Seer, Inc. saw revenue fall 14.0% to $14.08M over the twelve months to Sep 30, 2026. Free cash flow was -$46.35M. At the latest close the market valued the company at $88.04M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $88.04M
- P/E ratio
- –
- Price to sales
- 6.25
- Price to book
- 0.41
- Dividend yield
- 0.00%
- Free cash flow yield
- -52.65%
Fundamentals
- Revenue
- $14.08M
- Net income
- -$63.47M
- Free cash flow
- -$46.35M
Trading
- Next earnings
- Feb 25, 2027 (estimated, after the close)
- Previous close
- $1.59
- Open
- $1.60
- Day's range
- $1.56 – $1.65
- Volume
- 62,808
- Average volume (20 days)
- 177,586
- Beta (5 years)
- 2.12
- 52-week range
- $1.55 – $2.38
- RSI (14 days)
- 28.9
- Volatility (1 year)
- 56.1%
- Relative volume
- 0.62×
- WACC
- 15.5%
On 2 of our idea lists: Net-nets, More cash than they're worth
Market cap history
Month-end market cap since 2021, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | SEER | S&P 500 | Difference | SEER per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -26.0% | -2.7% | −23.4 pts | ||
| 3 months | -25.7% | -1.7% | −24.0 pts | ||
| Year to date | -13.1% | +11.9% | −25.0 pts | ||
| 1 year | -23.6% | +12.0% | −35.5 pts | ||
| 3 years | +1.9% | +78.2% | −76.3 pts | +0.6% | +21.2% |
| 5 years | -95.0% | +73.2% | −168.2 pts | -45.0% | +11.6% |
Seven years at a glance
Fiscal years 2019 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Seer filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- News
- Results
- News
- News
- News
About Seer
Laboratory Analytical Instruments
Seer, Inc. is a life sciences technology company that provides platforms for unbiased, deep, and large-scale proteomic analysis. Its core offering, the Proteograph Product Suite, consists of consumable assays—including the Proteograph ONE assay—an automation instrument such as the SP200, and data analysis software. By utilizing engineered nanoparticle technology, the system enables peptide-level resolution across complex samples without relying on predefined binding epitopes. The company primarily serves researchers in proteomics and genomics across academic institutions, biopharmaceutical companies, biobanks, and clinical research organizations.
Company profile, executives and historySeer stock: common questions
What is Seer's stock price?
SEER closed at $1.59 on Nov 12, 2026, up 0.00% on the day. Over the past 52 weeks it traded between $1.55 and $2.38.
What is Seer's market cap?
Seer was worth $88.04M at the close on Nov 12, 2026: the share price times the diluted shares outstanding.
How much revenue does Seer make?
Seer reported revenue of $14.08M for the twelve months to Sep 30, 2026, down 14.0% from a year earlier.
Does Seer pay a dividend?
No. Seer has not paid a cash dividend over the last twelve months.
When does Seer report earnings next?
Seer is expected to report Q4 FY2026 results on Feb 25, 2027, after the close. The date is estimated from its past reporting pattern until the company confirms it.
How has SEER stock performed over the past year?
Including dividends, SEER returned -23.6% over the past year, against +12.0% for the S&P 500.
How many SEER shares are sold short?
0M shares were sold short at the latest FINRA report, 0.20% of the float, or 1.0 days of average trading volume.
Who are Seer's competitors?
Companies most similar to Seer by business, industry and size include BNGO, RPID, LCTC, PRPO, SCND.
See a number that looks wrong?